[1] |
Mao C, Xiang Y, Liu X, et al. Repeatable photodynamic therapy with triggered signaling pathways of fibroblast cell proliferation and differentiation to promote bacteria-accompanied wound healing[J]. ACS Nano, 2018, 12(2): 1747-1759.
|
[2] |
Wang Y, Ashbaugh AG, Dikeman DA, et al. Interleukin-1β and tumor necrosis factor are essential in controlling an experimental orthopedic implant-associated infection[J]. J Orthop Res, 2020, 38(8):1800-1809.
|
[3] |
Jung SW, Oh SH, Lee IS, et al. In situ gelling hydrogel with anti-bacterial activity and bone healing property for treatment of osteomyelitis[J]. Tissue Eng Regen Med, 2019, 16(5): 479-490.
|
[4] |
Ashbaugh AG, Jiang X, Zheng J, et al. Polymeric nanofiber coating with tunable combinatorial antibiotic delivery prevents biofilm-associated infection in vivo[J]. Proc Natl Acad Sci USA, 2016, 113(45): E6919-E6928. DOI: 10.1073/pnas.1613722113.
|
[5] |
Jian S, Zhu J, Jiang S, et al. Nanofibers with diameter below one nanometer from electrospinning[J]. RSC Adv, 2018, 8(9): 4794-4802.
|
[6] |
Zupančič Š. Core-shell nanofibers as drug delivery systems[J]. Acta Pharm, 2019, 69(2): 131-153.
|
[7] |
Zupančič Š, Sinha-Ray S, Sinha-Ray S, et al. Controlled release of ciprofloxacin from core-shell nanofibers with monolithic or blended core[J]. Mol Pharm, 2016, 13(4): 1393-1404.
|
[8] |
Pelipenko J, Kocbek P, Kristl J. Critical attributes of nanofibers: preparation, drug loading, and tissue regeneration[J]. Int J Pharm, 2015, 484(1-2): 57-74.
|
[9] |
Han D, Steckl AJ. Coaxial electrospinning formation of complex polymer fibers and their applications[J]. Chem Plus Chem, 2019, 84(10): 1453-1497.
|
[10] |
Frizzell H, Ohlsen TJ, Woodrow KA. Protein-loaded emulsion electrospun fibers optimized for bioactivity retention and pH-controlled release for peroral delivery of biologic therapeutics[J]. Int J Pharm, 2017, 533(1): 99-110.
|
[11] |
Illangakoon UE, Yu DG, Ahmad BS, et al. 5-Fluorouracil loaded Eudragit fibers prepared by electrospinning[J]. Int J Pharm, 2015, 495(2): 895-902.
|
[12] |
Jia D, Gao Y, Williams GR. Core/shell poly(ethylene oxide)/Eudragit fibers for site-specific release[J]. Int J Pharm, 2017, 523(1): 376-385.
|
[13] |
Jin M, Yu DG, Wang X, et al. Electrospun contrast-agent-loaded fibers for colon-targeted MRI[J]. Adv Healthc Mater, 2016, 5(8): 977-985.
|
[14] |
Zupančič Š, Preem L, Kristl J, et al. Impact of PCL nanofiber mat structural properties on hydrophilic drug release and antibacterial activity on periodontal pathogens[J]. Eur J Pharm Sci, 2018, 122: 347-358.
|
[15] |
Shalumon KT, Sheu C, Chen CH, et al. Multi-functional electrospun antibacterial core-shell nanofibrous membranes for prolonged prevention of post-surgical tendon adhesion and inflammation[J]. Acta Biomater, 2018, 72:121-136.
|
[16] |
Liu F, Wang X, Chen T, et al. Hydroxyapatite/silver electrospun fibers for anti-infection and osteoinduction[J]. J Adv Res, 2020, 21: 91-102.
|
[17] |
Mathew A, Vaquette C, Hashimi S, et al. Antimicrobial and immunomodulatory surface-functionalized electrospun membranes for bone regeneration[J/OL]. Adv Healthcare Mater, 2017, 6(10): 1601345. DOI: 10.1002/adhm.201601345.
|
[18] |
Ivashchenko O, Woźniak A, Coy E, et al. Release and cytotoxicity studies of magnetite/Ag/antibiotic nanoparticles: an interdependent relationship[J]. Colloids Surf B Biointerfaces, 2017, 152: 85-94.
|
[19] |
Wang L, Zhang L, Yan J, et al. Electrospun vancomycin-loaded coating on titanium implants for the prevention of implant-associated infections[J/OL]. Int J Nanomed, 2014: 3027. DOI: 10.2147/ijn.s63991.
|
[20] |
Fathi M, Akbari B, Taheriazam A. Antibiotics drug release controlling and osteoblast adhesion from Titania nanotubes arrays using silk fibroin coating[J/OL]. Mater Sci Eng C Mater Biol Appl, 2019, 103: 109743. DOI: 10.1016/j.msec.2019.109743.
|
[21] |
Song W, Yu X, Markel DC, et al. Coaxial PCL/PVA electrospun nanofibers: osseointegration enhancer and controlled drug release device[J/OL]. Biofabrication, 2013, 5(3): 035006. DOI: 10.1088/1758-5082/5/3/035006.
|
[22] |
Hall-Stoodley L, Costerton JW, Stoodley P. Bacterial biofilms: from the Natural environment to infectious diseases[J]. Nat Rev Microbiol, 2004, 2(2): 95-108.
|
[23] |
Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections[J]. Science, 1999, 284(5418): 1318-1322.
|
[24] |
Baddour LM, Epstein AE, Erickson CC, et al. Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association[J]. Circulation, 2010, 121(3):458-477.
|
[25] |
Lim SH, Mao HQ. Electrospun scaffolds for stem cell engineering[J]. Adv Drug Deliv Rev, 2009, 61(12): 1084-1096.
|
[26] |
Chou SF, Carson D, Woodrow KA. Current strategies for sustaining drug release from electrospun nanofibers[J]. J Control Release, 2015, 220(Pt B): 584-591.
|
[27] |
Dash TK, Konkimalla VB. Poly--caprolactone based formulations for drug delivery and tissue engineering: a review[J]. J Control Release, 2012, 158(1): 15-33.
|
[28] |
Jain RA. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices[J]. Biomaterials, 2000, 21(23): 2475-2490.
|
[29] |
Osmon DR, Berbari EF, Berendt AR, et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the infectious diseases society of America[J/OL]. Clin Infect Dis, 2013, 56(1): e1-e25. DOI: 10.1093/cid/cis803.
|
[30] |
Diefenbeck M, Mückley T, Hofmann GO. Prophylaxis and treatment of implant-related infections by local application of antibiotics[J]. Injury, 2006, 37(Suppl 2): S95-S104.
|